Automated lipid nanoparticle production could accelerate the development of RNA therapies

MIT researchers have developed a faster, more precisely controlled method for producing lipid nanoparticles used to package RNA vaccines and other nucleic acid therapies. The approach could accelerate development of these treatments by improving control over particle size and shape.